$CCTSF
Cactus Acquisition Corp. 1 Ltd

2022 Q4 Form 10-K Financial Statement

#000121390023024626 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $311.0K $967.0K
YoY Change -18.51% 45.2%
Operating Profit
YoY Change
Interest Expense $1.091M $1.861M
YoY Change 54450.0% 92950.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $780.0K $894.0K
YoY Change -305.46% -234.64%
Income Tax
% Of Pretax Income
Net Earnings $780.0K $894.0K
YoY Change -305.46% -234.64%
Net Earnings / Revenue
Basic Earnings Per Share $0.09
Diluted Earnings Per Share $0.05 $0.06
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $243.0K $243.0K
YoY Change -75.08% -75.08%
Cash & Equivalents $243.0K $243.0K
Short-Term Investments
Other Short-Term Assets $275.0K $275.0K
YoY Change -17.42% -17.42%
Inventory
Prepaid Expenses $275.0K
Receivables
Other Receivables
Total Short-Term Assets $518.0K $518.0K
YoY Change -60.4% -60.4%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $130.9M $130.9M
YoY Change 1.23% 1.23%
Total Long-Term Assets $130.9M $130.9M
YoY Change 1.23% 1.23%
TOTAL ASSETS
Total Short-Term Assets $518.0K $518.0K
Total Long-Term Assets $130.9M $130.9M
Total Assets $131.4M $131.4M
YoY Change 0.61% 0.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $12.00K $12.00K
YoY Change -7.69% -7.69%
Deferred Revenue
YoY Change
Short-Term Debt $130.0K $130.0K
YoY Change -42.73% -42.73%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $142.0K $142.0K
YoY Change -40.83% -40.83%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.428M $4.428M
YoY Change 0.0% 0.0%
Total Long-Term Liabilities $4.428M $4.428M
YoY Change 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $142.0K $142.0K
Total Long-Term Liabilities $4.428M $4.428M
Total Liabilities $4.570M $4.570M
YoY Change -2.1% -2.1%
SHAREHOLDERS EQUITY
Retained Earnings -$4.052M
YoY Change 31.43%
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.052M $126.8M
YoY Change
Total Liabilities & Shareholders Equity $131.4M $131.4M
YoY Change 0.61% 0.61%

Cashflow Statement

Concept 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $780.0K $894.0K
YoY Change -305.46% -234.64%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $870.0K $1.129M
YoY Change -200.85% -209.4%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities 870.0K $1.129M
Cash From Investing Activities
Cash From Financing Activities 0.000 0.000
Net Change In Cash 870.0K $1.129M
YoY Change -99.33% -99.13%
FREE CASH FLOW
Cash From Operating Activities $870.0K $1.129M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-40981
CY2022 dei Entity Registrant Name
EntityRegistrantName
Cactus Acquisition Corp. 1 Ltd.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
4B Cedar Brook Drive
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Cranbury
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08512
CY2022 dei City Area Code
CityAreaCode
(609)
CY2022 dei Local Phone Number
LocalPhoneNumber
495-2222
CY2022 dei Security12b Title
Security12bTitle
Class A ordinary shares, par value $0.0001 per share
CY2022 dei Trading Symbol
TradingSymbol
CCTS
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
126372235 usd
CY2022 dei Auditor Name
AuditorName
Kesselman & Kesselman
CY2022 dei Auditor Location
AuditorLocation
Tel-Aviv, Israel
CY2022 dei Auditor Firm
AuditorFirmId
1309
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
243000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
975000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
275000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
333000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
518000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1308000 usd
CY2021Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
275000 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
130893000 usd
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
129032000 usd
CY2022Q4 us-gaap Assets
Assets
131411000 usd
CY2021Q4 us-gaap Assets
Assets
130615000 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
12000 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
13000 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
130000 usd
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
227000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
142000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
240000 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4428000 usd
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4428000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4570000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
4668000 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
130893000 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
129030000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4052000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3083000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4052000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3083000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
131411000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
130615000 usd
CY2022 us-gaap Interest Income Securities Other Us Government
InterestIncomeSecuritiesOtherUSGovernment
1861000 usd
us-gaap Interest Income Securities Other Us Government
InterestIncomeSecuritiesOtherUSGovernment
2000 usd
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
967000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
666000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
894000 usd
us-gaap Net Income Loss
NetIncomeLoss
-664000 usd
CY2022 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
12650000 shares
us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
2915430 shares
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
CY2022 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
3162500 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2853662 shares
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0.06 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
7300000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
8835000 usd
cctsu Change In Value Of Class A Common Stock Subject To Possible Redemption
ChangeInValueOfClassACommonStockSubjectToPossibleRedemption
-18579000 usd
us-gaap Net Income Loss
NetIncomeLoss
-664000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3083000 usd
CY2022 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-1863000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
894000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4052000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
894000 usd
us-gaap Net Income Loss
NetIncomeLoss
-664000 usd
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-333000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
608000 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-1000 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
13000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-97000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
227000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1129000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1032000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
126500000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
7300000 usd
cctsu Payment Of Underwriting Commissions And Offering Expenses
PaymentOfUnderwritingCommissionsAndOfferingExpenses
-2786000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
300000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
300000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
131039000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1129000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
130007000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130007000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
131136000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130007000 usd
CY2022Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
243000 usd
CY2021Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
975000 usd
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
130893000 usd
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
129032000 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
131136000 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
130007000 usd
us-gaap Stock Issued1
StockIssued1
4428000 usd
CY2021Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
12650000 shares
CY2022Q4 us-gaap Common Stock Held In Trust
CommonStockHeldInTrust
129030000.00 usd
CY2022 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
126500000 usd
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2530000 usd
CY2022 cctsu Redemption Value
RedemptionValue
10.2
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
1
CY2022 cctsu Business Combination Term
BusinessCombinationTerm
P18M
CY2022 cctsu Interest To Pay Dissolution Expenses
InterestToPayDissolutionExpenses
100000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0.56in"/><td style="width: 0.25in; text-align: left"><b>a.</b></td><td style="text-align: left"><b>Use of estimates in the preparation of financial statement</b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: left; text-indent: -0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.8in; text-align: left">The preparation of the financial statement in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates and such differences may have a material impact on the Company’s financial statement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: left"> </p>
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
126500000 usd
cctsu Proceeds Allocated To Public Warrants
ProceedsAllocatedToPublicWarrants
9370000 usd
CY2022Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
130893000 usd
CY2022 cctsu Net Tangible Assets
NetTangibleAssets
5000000 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
6679000 usd
cctsu Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
18579000 usd
CY2021Q4 cctsu Class A Common Stock Subject To Possible Redemption
ClassACommonStockSubjectToPossibleRedemption
129030000 usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1863000 usd
CY2022Q4 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
130893000 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0.56in"/><td style="width: 0.25in; text-align: left"><b>h.</b></td><td style="text-align: left"><b>Concentration of Credit Risk</b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.5pt; text-align: left"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.8in; text-align: left">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250 thousand. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p>
CY2022 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.50 pure
CY2022Q4 us-gaap Common Unit Issued
CommonUnitIssued
12650000 shares
CY2022 cctsu Sponsor Aggregate To Purchased
SponsorAggregateToPurchased
4866667 shares
CY2022 us-gaap Payments For Repurchase Of Private Placement
PaymentsForRepurchaseOfPrivatePlacement
7300000 usd
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
11.5
CY2022 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
0.01
CY2022Q4 cctsu Exceeds Per Share
ExceedsPerShare
18 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
894000 usd
us-gaap Net Income Loss
NetIncomeLoss
-664000 usd
CY2022 us-gaap Interest And Dividend Income Securities Other
InterestAndDividendIncomeSecuritiesOther
1861000 usd
us-gaap Interest And Dividend Income Securities Other
InterestAndDividendIncomeSecuritiesOther
2000 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-967000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-666000 usd
CY2022 cctsu Loss Attributable To Class A Ordinary Shareholders
LossAttributableToClassAOrdinaryShareholders
-774 shares
cctsu Loss Attributable To Class A Ordinary Shareholders
LossAttributableToClassAOrdinaryShareholders
-336 shares
CY2022 cctsu Accretion On Class A Ordinary Shares Subject To Possible Redemption1
AccretionOnClassAOrdinarySharesSubjectToPossibleRedemption1
1861 shares
cctsu Accretion On Class A Ordinary Shares Subject To Possible Redemption1
AccretionOnClassAOrdinarySharesSubjectToPossibleRedemption1
2532 shares
CY2022 cctsu Temporary Equity Other Changess1
TemporaryEquityOtherChangess1
1087 shares
cctsu Temporary Equity Other Changess1
TemporaryEquityOtherChangess1
2196 shares
CY2022 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
12650000 shares
us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
2915430 shares
CY2022 cctsu Loss Attributable To Class B Ordinary Shareholders
LossAttributableToClassBOrdinaryShareholders
-193 shares
cctsu Loss Attributable To Class B Ordinary Shareholders
LossAttributableToClassBOrdinaryShareholders
-329 shares
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-2532000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-193000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2841000 usd
CY2022 cctsu Weighted Average Of Class B Ordinary Shares Outstanding
WeightedAverageOfClassBOrdinarySharesOutstanding
3162500
cctsu Weighted Average Of Class B Ordinary Shares Outstanding
WeightedAverageOfClassBOrdinarySharesOutstanding
2853662
CY2021Q2 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
10000 usd
CY2022Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
450000 usd
CY2022Q1 us-gaap Debt Instrument Convertible Conversion Price Decrease
DebtInstrumentConvertibleConversionPriceDecrease
1.5
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
CY2022 us-gaap Deferred Compensation Arrangement With Individual Cash Awards Granted Percentage
DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage
0.035 pure
CY2022 cctsu Gross Proceeds
GrossProceeds
4428000 usd
CY2022 cctsu Issued And Sold An Aggregate
IssuedAndSoldAnAggregate
12650000 shares
CY2022Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10
CY2022 cctsu Total Consideration Amount
TotalConsiderationAmount
126500000 usd
CY2021Q2 cctsu Total Consideration Amount
TotalConsiderationAmount
25000 usd
CY2021Q4 us-gaap Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears
PreferredStockPerShareAmountsOfPreferredDividendsInArrears
0.1
CY2021Q4 cctsu Aggregate Of Founder Shares Outstandings
AggregateOfFounderSharesOutstandings
3162500 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
usd
CY2022Q4 cctsu Common Stock Value1
CommonStockValue1
usd
CY2021Q4 cctsu Common Stock Value1
CommonStockValue1
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001865861

Files In Submission

Name View Source Status
0001213900-23-024626-index-headers.html Edgar Link pending
0001213900-23-024626-index.html Edgar Link pending
0001213900-23-024626.txt Edgar Link pending
0001213900-23-024626-xbrl.zip Edgar Link pending
cctsu-20221231.xsd Edgar Link pending
f10k2022ex31-1_cactusacq1.htm Edgar Link pending
f10k2022ex31-2_cactusacq1.htm Edgar Link pending
f10k2022ex32-1_cactusacq1.htm Edgar Link pending
f10k2022ex4-5_cactusacq1.htm Edgar Link pending
f10k2022_cactusacq1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
cctsu-20221231_def.xml Edgar Link unprocessable
cctsu-20221231_cal.xml Edgar Link unprocessable
cctsu-20221231_lab.xml Edgar Link unprocessable
cctsu-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
f10k2022_cactusacq1_htm.xml Edgar Link completed
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending